The global Pharmaceutical Sterility Testing market, valued at USD 1.45 billion in 2022, is projected to surge to USD 3.68 billion by 2030, expanding at a compound annual growth rate (CAGR) of 12.1% over the forecast period from 2023 to 2030. The market growth is primarily fueled by the increasing demand for sterility testing in the pharmaceutical and biotechnology sectors, alongside...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian